Copyright Reports & Markets. All rights reserved.

Global Human Rabies Vaccines Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Human Rabies Vaccines

      • 1.1 Definition of Human Rabies Vaccines
      • 1.2 Human Rabies Vaccines Segment by Type
        • 1.2.1 Global Human Rabies Vaccines Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Vero Cell Rabies Vaccine
        • 1.2.3 BHK
        • 1.2.4 Chick Embryo Cell Rabies Vaccine
        • 1.2.5 Others
      • 1.3 Human Rabies Vaccines Segment by Applications
        • 1.3.1 Global Human Rabies Vaccines Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Pre-Exposure Prophylaxis
        • 1.3.3 Post-Exposure Prophylaxis
      • 1.4 Global Human Rabies Vaccines Overall Market
        • 1.4.1 Global Human Rabies Vaccines Revenue (2014-2025)
        • 1.4.2 Global Human Rabies Vaccines Production (2014-2025)
        • 1.4.3 North America Human Rabies Vaccines Status and Prospect (2014-2025)
        • 1.4.4 Europe Human Rabies Vaccines Status and Prospect (2014-2025)
        • 1.4.5 China Human Rabies Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Japan Human Rabies Vaccines Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Human Rabies Vaccines Status and Prospect (2014-2025)
        • 1.4.8 India Human Rabies Vaccines Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Human Rabies Vaccines
      • 2.3 Manufacturing Process Analysis of Human Rabies Vaccines
      • 2.4 Industry Chain Structure of Human Rabies Vaccines

      3 Development and Manufacturing Plants Analysis of Human Rabies Vaccines

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Human Rabies Vaccines Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Human Rabies Vaccines
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Human Rabies Vaccines Production and Capacity Analysis
      • 4.2 Human Rabies Vaccines Revenue Analysis
      • 4.3 Human Rabies Vaccines Price Analysis
      • 4.4 Market Concentration Degree

      5 Human Rabies Vaccines Regional Market Analysis

      • 5.1 Human Rabies Vaccines Production by Regions
        • 5.1.1 Global Human Rabies Vaccines Production by Regions
        • 5.1.2 Global Human Rabies Vaccines Revenue by Regions
      • 5.2 Human Rabies Vaccines Consumption by Regions
      • 5.3 North America Human Rabies Vaccines Market Analysis
        • 5.3.1 North America Human Rabies Vaccines Production
        • 5.3.2 North America Human Rabies Vaccines Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Human Rabies Vaccines Import and Export
      • 5.4 Europe Human Rabies Vaccines Market Analysis
        • 5.4.1 Europe Human Rabies Vaccines Production
        • 5.4.2 Europe Human Rabies Vaccines Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Human Rabies Vaccines Import and Export
      • 5.5 China Human Rabies Vaccines Market Analysis
        • 5.5.1 China Human Rabies Vaccines Production
        • 5.5.2 China Human Rabies Vaccines Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Human Rabies Vaccines Import and Export
      • 5.6 Japan Human Rabies Vaccines Market Analysis
        • 5.6.1 Japan Human Rabies Vaccines Production
        • 5.6.2 Japan Human Rabies Vaccines Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Human Rabies Vaccines Import and Export
      • 5.7 Southeast Asia Human Rabies Vaccines Market Analysis
        • 5.7.1 Southeast Asia Human Rabies Vaccines Production
        • 5.7.2 Southeast Asia Human Rabies Vaccines Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Human Rabies Vaccines Import and Export
      • 5.8 India Human Rabies Vaccines Market Analysis
        • 5.8.1 India Human Rabies Vaccines Production
        • 5.8.2 India Human Rabies Vaccines Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Human Rabies Vaccines Import and Export

      6 Human Rabies Vaccines Segment Market Analysis (by Type)

      • 6.1 Global Human Rabies Vaccines Production by Type
      • 6.2 Global Human Rabies Vaccines Revenue by Type
      • 6.3 Human Rabies Vaccines Price by Type

      7 Human Rabies Vaccines Segment Market Analysis (by Application)

      • 7.1 Global Human Rabies Vaccines Consumption by Application
      • 7.2 Global Human Rabies Vaccines Consumption Market Share by Application (2014-2019)

      8 Human Rabies Vaccines Major Manufacturers Analysis

      • 8.1 Sanofi Pasteur，Inc.
        • 8.1.1 Sanofi Pasteur，Inc. Human Rabies Vaccines Production Sites and Area Served
        • 8.1.2 Sanofi Pasteur，Inc. Product Introduction, Application and Specification
        • 8.1.3 Sanofi Pasteur，Inc. Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis Vaccines and Diagnostics Ltd.
        • 8.2.1 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Production Sites and Area Served
        • 8.2.2 Novartis Vaccines and Diagnostics Ltd. Product Introduction, Application and Specification
        • 8.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Cadila Pharmaceuticals Ltd.
        • 8.3.1 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Production Sites and Area Served
        • 8.3.2 Cadila Pharmaceuticals Ltd. Product Introduction, Application and Specification
        • 8.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 GlaxoSmithKline Biologicals
        • 8.4.1 GlaxoSmithKline Biologicals Human Rabies Vaccines Production Sites and Area Served
        • 8.4.2 GlaxoSmithKline Biologicals Product Introduction, Application and Specification
        • 8.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Merck＆Co Inc.
        • 8.5.1 Merck＆Co Inc. Human Rabies Vaccines Production Sites and Area Served
        • 8.5.2 Merck＆Co Inc. Product Introduction, Application and Specification
        • 8.5.3 Merck＆Co Inc. Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Wyeth pharmaceuticals
        • 8.6.1 Wyeth pharmaceuticals Human Rabies Vaccines Production Sites and Area Served
        • 8.6.2 Wyeth pharmaceuticals Product Introduction, Application and Specification
        • 8.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Berna Biotech Ltd.
        • 8.7.1 Berna Biotech Ltd. Human Rabies Vaccines Production Sites and Area Served
        • 8.7.2 Berna Biotech Ltd. Product Introduction, Application and Specification
        • 8.7.3 Berna Biotech Ltd. Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Medimmune LLC
        • 8.8.1 Medimmune LLC Human Rabies Vaccines Production Sites and Area Served
        • 8.8.2 Medimmune LLC Product Introduction, Application and Specification
        • 8.8.3 Medimmune LLC Human Rabies Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Human Rabies Vaccines Market

      • 9.1 Global Human Rabies Vaccines Market Trend Analysis
        • 9.1.1 Global Human Rabies Vaccines Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Human Rabies Vaccines Regional Market Trend
        • 9.2.1 North America Human Rabies Vaccines Forecast 2019-2025
        • 9.2.2 Europe Human Rabies Vaccines Forecast 2019-2025
        • 9.2.3 China Human Rabies Vaccines Forecast 2019-2025
        • 9.2.4 Japan Human Rabies Vaccines Forecast 2019-2025
        • 9.2.5 Southeast Asia Human Rabies Vaccines Forecast 2019-2025
        • 9.2.6 India Human Rabies Vaccines Forecast 2019-2025
      • 9.3 Human Rabies Vaccines Market Trend (Product Type)
      • 9.4 Human Rabies Vaccines Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Human Rabies Vaccines Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.
        Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low immunization rates in pets, and rising friendliness with pets are drivers estimated to boost growth of human rabies vaccine market.

        The global Human Rabies Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Human Rabies Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Rabies Vaccines market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Human Rabies Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Human Rabies Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Sanofi Pasteur，Inc.
        Novartis Vaccines and Diagnostics Ltd.
        Cadila Pharmaceuticals Ltd.
        GlaxoSmithKline Biologicals
        Merck＆Co Inc.
        Wyeth pharmaceuticals
        Berna Biotech Ltd.
        Medimmune LLC

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Vero Cell Rabies Vaccine
        BHK
        Chick Embryo Cell Rabies Vaccine
        Others

        Segment by Application
        Pre-Exposure Prophylaxis
        Post-Exposure Prophylaxis

        Buy now